Phase IIa study of copanlisib, a novel phosphatidylinositol-3 kinase inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma

Kim Linton; Martin Dreyling; Pier Luigi Zinzani; Krimo Bouabdallah; Dominique Bron; David Cunningham; Catherine Thieblemont; Eric Van den Neste; Umberto Vitolo; Julia Grunert; Marius Giurescu; Silvia Mappa; Barrett H Childs; Franck Morschhauser

Phase IIa study of copanlisib, a novel phosphatidylinositol-3 kinase inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma

Kim Linton, Martin Dreyling, Pier Luigi Zinzani, Krimo Bouabdallah, Dominique Bron, David Cunningham, Catherine Thieblemont, Eric Van den Neste, Umberto Vitolo, Julia Grunert, Marius Giurescu, Silvia Mappa, Barrett H Childs, Franck Morschhauser

Research output: Contribution to conference › Poster

Original language	English
Publication status	Published - Nov 2014
Event	EORTC-NCI-AACR meeting - Barcelona, Spain Duration: 1 Jan 1824 → …

Conference

Conference	EORTC-NCI-AACR meeting
City	Barcelona, Spain
Period	1/01/24 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Linton, K., Dreyling, M., Zinzani, P. L., Bouabdallah, K., Bron, D., Cunningham, D., Thieblemont, C., Neste, E. V. D., Vitolo, U., Grunert, J., Giurescu, M., Mappa, S., Childs, B. H., & Morschhauser, F. (2014). Phase IIa study of copanlisib, a novel phosphatidylinositol-3 kinase inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma. Poster session presented at EORTC-NCI-AACR meeting, Barcelona, Spain.

@conference{8eff125d6d604d618ee90ae29a65de94,

title = "Phase IIa study of copanlisib, a novel phosphatidylinositol-3 kinase inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma",

author = "Kim Linton and Martin Dreyling and Zinzani, {Pier Luigi} and Krimo Bouabdallah and Dominique Bron and David Cunningham and Catherine Thieblemont and Neste, {Eric Van den} and Umberto Vitolo and Julia Grunert and Marius Giurescu and Silvia Mappa and Childs, {Barrett H} and Franck Morschhauser",

year = "2014",

month = nov,

language = "English",

note = "EORTC-NCI-AACR meeting ; Conference date: 01-01-1824",

}

Linton, K, Dreyling, M, Zinzani, PL, Bouabdallah, K, Bron, D, Cunningham, D, Thieblemont, C, Neste, EVD, Vitolo, U, Grunert, J, Giurescu, M, Mappa, S, Childs, BH & Morschhauser, F 2014, 'Phase IIa study of copanlisib, a novel phosphatidylinositol-3 kinase inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma', EORTC-NCI-AACR meeting, Barcelona, Spain, 1/01/24.

TY - CONF

T1 - Phase IIa study of copanlisib, a novel phosphatidylinositol-3 kinase inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma

AU - Linton, Kim

AU - Dreyling, Martin

AU - Zinzani, Pier Luigi

AU - Bouabdallah, Krimo

AU - Bron, Dominique

AU - Cunningham, David

AU - Thieblemont, Catherine

AU - Neste, Eric Van den

AU - Vitolo, Umberto

AU - Grunert, Julia

AU - Giurescu, Marius

AU - Mappa, Silvia

AU - Childs, Barrett H

AU - Morschhauser, Franck

PY - 2014/11

Y1 - 2014/11

M3 - Poster

T2 - EORTC-NCI-AACR meeting

Y2 - 1 January 1824

ER -